Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
about
Hyperfractionated or accelerated radiotherapy for head and neck cancerThe Indian scenario of head and neck oncology - Challenging the dogmasThe fractionation conundrum: Are we still missing a piece of the puzzle?Impact and relationship of anterior commissure and time-dose factor on the local control of T1N0 glottic cancer treated by 6 MV photons.Effect of Prolonged Radiotherapy Treatment Time on Survival Outcomes after Intensity-Modulated Radiation Therapy in Nasopharyngeal CarcinomaFinal results of local-regional control and late toxicity of RTOG 9003: a randomized trial of altered fractionation radiation for locally advanced head and neck cancer.A Randomized Prospective Study of Concurrent Chemo-Radiotherapy vs Accelerated Hyperfractionation in Advanced Cancer of Head and Neck.Risk factors for clinician-reported symptom clusters in patients with advanced head and neck cancer in a phase 3 randomized clinical trial: RTOG 0129.Radiotherapy for laryngeal squamous cell carcinoma: current standards.Concomitant chemoradiotherapy versus altered fractionation radiotherapy in the radiotherapeutic management of locoregionally advanced head and neck squamous cell carcinoma: An adjusted indirect comparison meta-analysis.Organ preservation strategies: Review of literature and their applicability in developing nations.Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.Prospective randomized trial to compare the outcome and tolerability of delivering the same total dose of radiation in 61/2 weeks versus 51/2 weeks time in head and neck cancers.Final Report of a Prospective Randomized Trial to Evaluate the Dose-Response Relationship for Postoperative Radiation Therapy and Pathologic Risk Groups in Patients With Head and Neck Cancer.Long term results of comparison of concurrent low-dose daily cisplatin versus the standard weekly cisplatin with six fractions per week radiotherapy in locally advanced head neck cancer.Head and neck cancers: Safely preserving the talkRadiotherapy for laryngeal cancer—technical aspects and alternate fractionation.Prognostic factors for supraglottic laryngeal carcinoma: Importance of the unfit patient.Radiotherapy for laryngeal cancer-technical aspects and alternate fractionation.Adaptive Boost Target Definition in High-Risk Head and Neck Cancer Based on Multi-imaging Risk Biomarkers.Association of Time between Surgery and Adjuvant Therapy with Survival in Oral Cavity Cancer.Aspiration as a late complication after accelerated versus conventional radiotherapy in patients with head and neck cancer.When is chemotherapy in head and neck squamous cell carcinoma not indicated?Final Report of Radiation Therapy Oncology Group Protocol 9003: Provocative, but Limited Conclusions From Exploratory Analyses.Altered fractionation radiotherapy with or without chemotherapy in the treatment of head and neck cancer: a network meta-analysisIntensity-Modulated Radiotherapy with a Simultaneous Integrated Boost Combined with Chemotherapy in Stages III-IV Hypopharynx-Larynx Cancer: Treatment Compliance and Clinical Outcomes
P2860
Q24235527-FA8D1EED-4BA8-45D0-A1FB-C269EEE58E12Q28072546-07186EDA-47ED-4E83-A282-4116EF63A14DQ33357621-385A27D7-D743-42E2-9CB6-694C3EF0510DQ35071640-4BC1DABD-B17A-4ABB-A999-9BBAB43A549FQ35823230-25F85891-8C97-40C7-B945-7BDDE99BAE20Q36332315-DE31EB20-AB34-4CCD-9A95-D1CB540AEA84Q37435817-09929DF0-38FD-4465-922E-98BFE362C113Q37626932-B12EFA22-FA82-47CD-A721-57B48E066CE0Q37788244-0CBA5795-DC76-42C5-A81E-3E836D5BA1E1Q38193394-78685E1B-65E5-48C5-89CF-1FD8B25025E9Q38241209-F7B94011-0A4B-49C2-A758-19F76CC30CE1Q38400679-86C7C777-E084-4ACD-B4D5-6DE5ECEC0828Q38526243-F736C7B4-3708-4F68-8C5D-E3192F0CBF13Q40117385-CE4D7A93-FFFC-466B-A0E0-AB6FBA22D207Q41858833-CC5D046D-F8B6-4398-A9DA-09B95DDBB296Q42794006-DF86219D-E5AD-4D41-AEB9-CE37CF884A7FQ46322072-015E1A4B-A25D-40F3-9B4B-10C46265C26CQ47581242-02003548-8587-4B0B-893F-ACDCCED296A3Q48663507-8BE023E5-AC92-4C52-9A6A-ED68CE355EBEQ50084052-1301F7C8-9CEF-47FE-B999-38D00B7DAB9CQ50113593-A45D9D42-C8D9-472C-BFCE-9B644253D81FQ51550250-2BF80F63-B9A2-49DB-A9D8-C0471BD0B521Q53066629-7F94EB94-0FE3-45AB-9048-CEC9DBC32C24Q55035025-D76FF015-5AED-46AF-96ED-4A1FF4AF2BD1Q58764983-2E08FF5C-6112-459F-AA99-6A5C1AF801D5Q59051027-F0380EB3-20D5-4C4D-A420-0B6633F78347
P2860
Five versus six fractions of radiotherapy per week for squamous-cell carcinoma of the head and neck (IAEA-ACC study): a randomised, multicentre trial.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Five versus six fractions of r ...... randomised, multicentre trial.
@en
Five versus six fractions of r ...... randomised, multicentre trial.
@nl
type
label
Five versus six fractions of r ...... randomised, multicentre trial.
@en
Five versus six fractions of r ...... randomised, multicentre trial.
@nl
prefLabel
Five versus six fractions of r ...... randomised, multicentre trial.
@en
Five versus six fractions of r ...... randomised, multicentre trial.
@nl
P2093
P1433
P1476
Five versus six fractions of r ...... randomised, multicentre trial.
@en
P2093
Bidhu Kaylan Mohanti
Hideo Tatsuzaki
Jai Prakash Agarwal
Jens Overgaard
Maire Kuddu
Naseem Begum
Rubina Ali
Suman Bhasker
P304
P356
10.1016/S1470-2045(10)70072-3
P50
P577
2010-04-08T00:00:00Z